FDA Clears First Drug for Rare Genetic Causes of Severe Obesity ...Middle East

Medscape - News
Setmelanotide (Imcivree) is indicated for weight management in adults and children as young as 6 years with severe obesity driven by genetic deficits in the melanocortin-4 receptor pathway. FDA Approvals

Hence then, the article about fda clears first drug for rare genetic causes of severe obesity was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug for Rare Genetic Causes of Severe Obesity )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News